SMW Free Realtime Trade Alerts -- Fast Moving Stocks < $15 -- Join Today for FREE!!


( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
Loading VVUS News...
Health Technology » Pharmaceuticals Other
VRXValeant Pharmaceuticals International, Inc.
SHPGShire PLC Sponsored ADR
PRGOPerrigo Co. Plc
ENDPEndo International Plc
GWPHGW Pharmaceuticals PLC Sponsored ADR
MNKMallinckrodt Plc
UTHRUnited Therapeutics Corporation
JAZZJazz Pharmaceuticals Plc
ICPTIntercept Pharmaceuticals, Inc.
MDCOMedicines Company
HZNPHorizon Pharma plc
DEPODepomed, Inc.
AERIAerie Pharmaceuticals, Inc.
CTLTCatalent Inc

Company Profile

VIVUS, Inc. operates as a biopharmaceutical company, which develops innovative, next-generation therapies to address unmet needs in obesity, diabetes, sleep apnea and sexual health. The company's products include Qsymia Obesity, Qsymia Sleep Apnea, Qsymia Diabetes and Avanafil. VIVUS was founded by Virgil A. Place on April 16, 1991 and is headquartered in Mountain View, CA.